As of April 19, 2025, Silence Therapeutics (SLN) has a market cap of $0.15 billion USD. According to our data, Silence Therapeutics is ranked No.7267 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.15 B |
-54.35%
|
Dec 31, 2024 | $0.32 B |
-60.39%
|
Dec 29, 2023 | $0.82 B |
13.90%
|
Dec 30, 2022 | $0.72 B |
-36.17%
|
Dec 31, 2021 | $1.13 B |
8.59%
|
Dec 31, 2020 | $1.04 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Arrowhead Pharmaceuticals
ARWR
|
$1.54 B |
-0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.74 B |
0.000 M
|
![]() Germany
|
![]() Arcturus Therapeutics
ARCT
|
$0.29 B |
0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() Telesis Bio
TBIO
|
$1.64 M |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
Market Cap | = | SLN Stock Price | * | SLN Shares Outstanding |
= | $3.14 | * | 47.22 M | |
= | $0.15 B |